balstilimab,botensilimab
agenus
#agenus shows unprecedented activity for #botensilimab #balstilimab combination in #microsatellite stable #colorectalcancer at #esmoworldgicongress22 $agen 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.